Search
Sumario de resultados
TIpos de contenido
Fecha
-
CompanyIntegra Therapeutics S.L.
-
CompanyFlomics Biotech
-
Press releasePandemic consolidates the trend of job and talent growth in the biotech sector
Biotech companies are expanding their workforce amid the pandemic, accentuating in 2020 the growth trend of recent years, in which staff increased by 7.6% in 2019 and accounted for 12.8% of people
-
Press release
BIOSPAIN represents a boost for investment in a decisive year for biotechnology
The pandemic has provided an opportunity for Spanish biotechnology and private investment has increased by 50% in 2020. BIOSPAIN 2021, the reference Spanish trade fair for investment agents and
-
Press release
More than 160 spanish biotech companies seek out solutions for a greener industry
Most of these companies will be at the most important annual event for the sector, BIOSPAIN 2021, which will be held in Pamplona-Iruña from 27th September to 1rst October
-
Press release
2020 AseBio Report shows huge jump in Spanish biotechnology in pandemic year
Biotech companies launched 70% more products and services to market and Spain moved to eighth in the world in scientific production in biotechnology
-
Press release
Personalised medicine increases its activity by 40% in the last year and is becoming more ...
Precision medicine and personalised medicine products or services have gone from representing 12% of total launches to 52% in 2020. Navarra, which is hosting Biospain 2021, is one of the pioneering
-
-
NewORYZON reports results and corporate update for first half ended June 30, 2021
Oryzon Genomics, S.A., the Spanish company developing innovative epigenetic experimental therapies, announces results and progress in the first half of 2021
-
NewImmunostep develops a new serological test capable of differentiate vaccinated individuals...
The company announced the launch of a new antibody test that detects three types of antibodies against four proteins of the SARS-CoV-2 virus with a single blood sample and 99% of reliability
-
NewPETRA: The potencial of medical robots
The robot facilitates thyroid diagnosis by interacting with humans and making an assessment based on preset parameters
-
NewTECNIC Bioprocess Equipment Manufacturing presents the new range of ePILOT bioreactors
The new ePILOT bioreactors, ranging from 10 to 50 litres in useful volume, feature an extremely compact design ideal for tight spaces.
-
NewLaboratorios Rubio continues with its international expansion plan
Laboratorios Rubio S.A has submitted to the FDA all the documentation for the registry of 2 blood sample based diagnostic tests, as first step with its international expansion strategy
-
NewAyming for the best version of Spanish biotechnology
Biocompanies are synonymous of innovation and transformation, as they have always outlined each area of their activity in order to concentrate talent, new technologies and research
-
NewAlmirall launches new call to establish partnerships in innovative therapies for skin dise...
AlmirallShare, the company’s R&D open innovation platform, and looks for partnering opportunities for new assets in order to offer breakthrough innovation and accelerate the generation of new
-
NewThe EMA validates Algenex's CrisBio® technology platform, for the manufacture of vaccines...
This European recommendation has validated the use of this technology to produce recombinant biologics and biocomponents
-
NewBCN HEALTH has participated in the "Global Thalassaemia Review 2021 Report" developed by t...
With the data obtained in the targeted literature, a cost-of-illness model has been developed to determine the cost of thalassaemia
-
New#InterviewBiospain2021 | The company born drinking a beer that ended up as the first to de...
3P Biopharmaceuticals operates globally, with 19 active projects worldwide and has positioned itself, after a difficult start in 2006, as a leader in the biologics manufacturing field in Spain
-
NewA FECYT report concludes that the entire innovation incentive scheme needs to be redesig...
GENESIS Biomed has participated in the preparation of the THINK TANK report "Patenting and/or publishing" by the FECYT, which covers the debate on publishing research or its transfer and exploitation
-
NewPersonalised medicine increases its activity by 40% in the last year and is becoming more ...
Precision medicine and personalised medicine products or services have gone from representing 12% of total launches to 52% in 2020. Navarra, which is hosting Biospain 2021, is one of the pioneering
-
NewORYZON receives approval to start EVOLUTION Phase IIb trial with vafidemstat in schizophre...
Clinical Trial Application approved by Spanish Drug Agency Primary objectives: to assess the effect of vafidemstat to address negative and cognitive symptoms in schizophrenia Second Phase IIb study of